TYRA-300

· Tyra Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TYRA-300, covering 2026-01-12 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer [Phase 2]

See pricing